Temporal interferon-gamma release response to Mycobacterium kansasii infection in an anorexia nervosa patient

References

1. American Psychiatric Association 2000 Diagnostic and Statistical Manual of Mental Disorders, 4th edn, Text Revision. Washington, DC: American Psychiatric Association;
   [Google Scholar]
2. Antoine D., Che D. 2012 Tuberculosis cases reported in France in 2010. Bulletin Epidémiologique Hebdomadaire, 285–287
3. Arend S. M., de Haas P., Leyten E., Rosenkrands I., Rigouts L., Andersen P., Mijs W., van Dissel J. T., van Soolingen D. 2005; ESAT-6 and CFP-10 in clinical versus environmental isolates of Mycobacterium kansasii. J Infect Dis 191:1301–1310 [View Article][PubMed]
   [Google Scholar]
4. Bocchino M., Chairadonna P., Matarese A., Bruzzese D., Salvatores M., Tronci M., Moscariello E., Galati D., Alma M. G. other authors 2010; Limited usefulness of QuantiFERON-TB Gold In-Tube for monitoring anti-tuberculosis therapy. Respir Med 104:1551–1556 [View Article][PubMed]
   [Google Scholar]
5. Bowers T. K., Eckert E. 1978; Leukopenia in anorexia nervosa. Lack of increased risk of infection. Arch Intern Med 138:1520–1523 [View Article][PubMed]
   [Google Scholar]
6. Brown R. F., Bartrop R., Beumont P., Birmingham C. L. 2005; Bacterial infections in anorexia nervosa: delayed recognition increases complications. Int J Eat Disord 37:261–265 [View Article][PubMed]
   [Google Scholar]
7. Carrara S., Vincenti D., Petrosillo N., Amicosante M., Girardi E., Goletti D. 2004; Use of a T cell-based assay for monitoring efficacy of antituberculosis therapy. Clin Infect Dis 38:754–756 [View Article][PubMed]
   [Google Scholar]
8. Chiappini E., Fossi F., Bonsignori F., Sollai S., Galli L., de Martino M. 2012; Utility of interferon-γ release assay results to monitor anti-tubercular treatment in adults and children. Clin Ther 34:1041–1048 [View Article][PubMed]
   [Google Scholar]
9. Devulder G., Pérouse de Montclos M., Flandrois J. P. 2005; A multigene approach to phylogenetic analysis using the genus Mycobacterium as a model. Int J Syst Evol Microbiol 55:293–302 [View Article][PubMed]
   [Google Scholar]
10. Ewer K., Millington K. A., Deeks J. J., Alvarez L., Bryant G., Lalvani A. 2006; Dynamic antigen-specific T-cell responses after point-source exposure to Mycobacterium tuberculosis.. Am J Respir Crit Care Med 174:831–839 [View Article][PubMed]
    [Google Scholar]
11. Feinberg J., Fieschi C., Doffinger R., Feinberg M., Leclerc T., Boisson-Dupuis S., Picard C., Bustamante J., Chapgier A. other authors 2004; Bacillus Calmette Guérin triggers the IL-12/IFN-γ axis by an IRAK-4- and NEMO-dependent, non-cognate interaction between monocytes, NK, and T lymphocytes. Eur J Immunol 34:3276–3284 [View Article][PubMed]
    [Google Scholar]
12. Gey van Pittius N. C., Sampson S. L., Lee H., Kim Y., van Helden P. D., Warren R. M. 2006; Evolution and expansion of the Mycobacterium tuberculosis PE and PPE multigene families and their association with the duplication of the ESAT-6 (esx) gene cluster regions. BMC Evol Biol 6:95 [View Article][PubMed]
    [Google Scholar]
13. Griffith D. E., Aksamit T., Brown-Elliott B. A., Catanzaro A., Daley C., Gordin F., Holland S. M., Horsburgh R., Huitt G. other authors 2007; An official ATS/IDSA statement: diagnosis, treatment, and prevention of nontuberculous mycobacterial diseases. Am J Respir Crit Care Med 175:367–416 [View Article][PubMed]
    [Google Scholar]
14. Hütter G., Ganepola S., Hofmann W. K. 2009; The hematology of anorexia nervosa. Int J Eat Disord 42:293–300 [View Article][PubMed]
    [Google Scholar]
15. Katiyar S. K., Sampath A., Bihari S., Mamtani M., Kulkarni H. 2008; Use of the QuantiFERON-TB Gold In-Tube test to monitor treatment efficacy in active pulmonary tuberculosis. Int J Tuberc Lung Dis 12:1146–1152[PubMed]
    [Google Scholar]
16. Kobashi Y., Mouri K., Miyashita N., Oka M. 2009a; Clinical usefulness of QuantiFERON TB-2G test for the early diagnosis of pulmonary Mycobacterium kansasii disease. Jpn J Infect Dis 62:239–241[PubMed]
    [Google Scholar]
17. Kobashi Y., Mouri K., Yagi S., Obase Y., Miyashita N., Okimoto N., Matsushima T., Kageoka T., Oka M. 2009b; Clinical evaluation of the QuantiFERON-TB Gold test in patients with non-tuberculous mycobacterial disease. Int J Tuberc Lung Dis 13:1422–1426[PubMed]
    [Google Scholar]
18. Mori T. 2009; Usefulness of interferon-gamma release assays for diagnosing TB infection and problems with these assays. J Infect Chemother 15:143–155 [View Article][PubMed]
    [Google Scholar]
19. Pai M., Joshi R., Dogra S., Mendiratta D. K., Narang P., Dheda K., Kalantri S. 2006; Persistently elevated T cell interferon-γ responses after treatment for latent tuberculosis infection among health care workers in India: a preliminary report. J Occup Med Toxicol 1:7 [View Article][PubMed]
    [Google Scholar]
20. Pertschuk M. J., Crosby L. O., Barot L., Mullen J. L. 1982; Immunocompetency in anorexia nervosa. Am J Clin Nutr 35:968–972[PubMed]
    [Google Scholar]
21. Shitrit D., Priess R., Peled N., Bishara G., Shlomi D., Kramer M. R. 2007; Differentiation of Mycobacterium kansasii infection from Mycobacterium tuberculosis infection: comparison of clinical features, radiological appearance, and outcome. Eur J Clin Microbiol Infect Dis 26:679–684 [View Article][PubMed]
    [Google Scholar]
22. van Ingen J., de Zwaan R., Dekhuijzen R., Boeree M., van Soolingen D. 2009; Region of difference 1 in nontuberculous Mycobacterium species adds a phylogenetic and taxonomical character. J Bacteriol 191:5865–5867 [View Article][PubMed]
    [Google Scholar]
23. van Zyl-Smit R. N., Zwerling A., Dheda K., Pai M. 2009; Within-subject variability of interferon-g assay results for tuberculosis and boosting effect of tuberculin skin testing: a systematic review. PLoS ONE 4:e8517 [View Article][PubMed]
    [Google Scholar]